MedTrace Logo

Trial Using Integuseal as Microbial Sealant for Arterial Bypass Surgery on Lower Extremities

NCT00940979 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 450

Last updated 2014-01-13

No results posted yet for this study

Summary

The purpose of this study is to prove a reduction of postoperative wound infections after direct preoperative use of a microbial sealant in the form of Integuseal for vascular procedures on lower extremities.

Conditions

  • Arterial Obstructive Diseases

Interventions

PROCEDURE

Application of Integuseal sealant

Microbial sealant (integuseal) applied with a sponge applicator

Sponsors & Collaborators

  • Kimberly-Clark Corporation

    collaborator INDUSTRY

  • Rijnstate Hospital

    lead OTHER

Principal Investigators

  • Michel MPJ Reijnen, MD · Rijstate hospital Arnhem the Netherlands

  • J. Klinkenbijl, MD

  • Sjoerd A de Beer, MD · Rijnstate Hospital Arnhem the Netherlands

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-01-31
Primary Completion
2011-04-30
Completion
2011-05-31

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00940979 on ClinicalTrials.gov